Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Gender differences in anaphylaxis

Salvati, Lorenzo*; Vitiello, Gianfranco*; Parronchi, Paola

Current Opinion in Allergy and Clinical Immunology: October 2019 - Volume 19 - Issue 5 - p 417–424
doi: 10.1097/ACI.0000000000000568
ANAPHYLAXIS AND INSECT ALLERGY: Edited by Gianenrico Senna and Mariana Castells
Buy

Purpose of review Is sexual dimorphism also true in anaphylaxis as described in other allergic diseases? Possible gender differences in the epidemiology, triggers, severity, outcomes of anaphylaxis as well as in the pathogenesis of the disease are discussed.

Recent findings Hormonal status and the X-chromosome-coded factors deeply involved in the regulation of T-cell and B-cell responses may influence the gender difference noticed in allergic diseases, such as asthma and rhinitis. Little is known if sex is also relevant for anaphylaxis, although the description of catamenial anaphylaxis is intriguing. However, epidemiologic bias, lack of reliable animal models for the human disease, differences into diagnostic codes and not harmonized clinical grading unfortunately represent hurdles to obtain meaningful information on this topic.

Summary The female sex predisposes to a dysregulation of the immune response as suggested by the increased prevalence of autoimmunity and atopy. In anaphylaxis, pathomechanisms are not fully disclosed, triggers are numerous and IgE-dependent mast cell degranulation only represents a part of the story. Improvement into the definition of the disease including a more careful coding system and better investigations about triggers seem the only way to allow a more precise assessment of the possible different risk for women to develop anaphylaxis.

Department of Experimental and Clinical Medicine, University of Firenze, Firenze, Italy

Correspondence to Paola Parronchi, MD, Department of Experimental and Clinical Medicine, University of Firenze, Largo Brambilla 3, 50134 Firenze, Italy. Tel: +39 557947421; e-mail: paola.parronchi@unifi.it

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.